-transparent.png){kind=logo}
The prevalence of von Willebrand's disease (VWD) in Western European countries and Israel was assessed. Possible patients were identified initially by questionnaire and those with plasma levels of von Willebrand factor antigen ( WFAg ; factor VIII related antigen) less than 1 u/dl (less than 1%) were confirmed by immunoradiometric assay performed at four reference centres. The prevalences of severe VWD in Scandinavian countries were similar to each other and about 10 times greater than those in other Western European countries. The prevalence in Israel was intermediate. The Registry will form the basis for future non- invasive epidemiological studies of atherosclerosis in these individuals.
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
April 1991,
Harefuah,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
November 1975,
British medical journal,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
November 1983,
British journal of haematology,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
November 1979,
The Journal of clinical investigation,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
April 1980,
The Journal of laboratory and clinical medicine,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
November 1977,
British medical journal,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
August 1982,
Blood,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
May 1991,
Mayo Clinic proceedings,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
November 1996,
Mayo Clinic proceedings,
P M Mannucci, and
A L Bloom, and
M J Larrieu, and
I M Nilsson, and
R R West
June 1962,
Nordisk medicin,
